@article{ATM22838,
author = {Zhiwei Zhang},
title = {No “optimal timing” of renal-replacement therapy in critically ill patients with acute kidney injury},
journal = {Annals of Translational Medicine},
volume = {6},
number = {Suppl 2},
year = {2018},
keywords = {},
abstract = {Acute kidney injury (AKI) represents a sudden decrease in renal function from a number of disparate causes (1). Using KDIGO (Kidney disease: Improving Global Outcomes) definition, a meta-analysis indicated that the world incidence rates of AKI were approximately 21% in adults and 33% in children (2). Acute tubular necrosis (ATN) accounts for the majority cases of AKI especially in critical care setting with mortality rate exceeding 50% (3). The current medical management of AKI/ATN, however, is limited to supportive care and renal-replacement therapy (RRT) if indicated, while various therapeutic modalities have been attempted without success.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/22838}
}